Related Experiment Video
Updated: Sep 27, 2025
06:46
Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
Published on: July 25, 2025
301
Subretinal Therapy: Technological Solutions to Surgical and Immunological Challenges
Reza Ladha1,2, Laure E Caspers1,2, François Willermain1,2
1Departments of Ophthalmology, Centre Hospitalier Universitaire Saint-Pierre and Brugmann, Brussels, Belgium.
Frontiers in Medicine
|April 11, 2022
Summary
Precise subretinal delivery is crucial for ocular gene and cellular therapies. Robotic technology offers standardized, reproducible delivery, minimizing iatrogenic damage and improving therapeutic outcomes.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Regenerative Medicine
Background:
- Ocular gene and cellular therapies require precise subretinal delivery.
- Manual delivery methods have limitations including iatrogenic damage, reflux, and variability.
- The eye's immune privilege influences responses to exogenous vectors and transplanted cells.
Purpose of the Study:
- To discuss the limitations of manual subretinal delivery.
- To explore the immunological considerations in ocular therapies.
- To highlight the advantages of robotic technology for precise ocular delivery.
Main Methods:
- Review of current subretinal delivery techniques.
- Discussion of ocular immune responses and immune privilege.
- Analysis of robotic technology for microprecision medical applications.
Main Results:
- Manual delivery is associated with significant limitations and risks.
- Understanding ocular immune responses is critical for therapeutic success.
- Robotic technology offers reproducible and standardized subretinal delivery.
Conclusions:
- Robotic-assisted subretinal delivery can overcome the limitations of manual methods.
- Precise and standardized delivery is essential for effective ocular gene and cellular therapies.
- Microprecision robotic technology holds promise for advancing ocular treatments.
